Reimbursement Scheme Ontozry® (12.5mg/25mg, 50 mg, 100 mg, 150mg)

24 March 2022

Reimbursement Scheme Ontozry® (12.5mg/25mg, 50 mg, 100 mg, 150mg)

The health insurer does not fully reimburse ONTOZRY® (12.5mg/25mg, 50 mg, 100 mg, 150mg)The producer of this medicine has therefore asked TBR Nederland to reimburse the costs of the Personal Contribution to the patient.

Conditions

The Personal Contribution for ONTOZRY® (12.5mg/25mg, 50 mg, 100 mg, 150 mg)  that is demonstrably charged to the patient by the health insurer as of the 1st of April 2022, will be fully reimbursed to a maximum of € 250,- per patient per year. ONTOZRY® 200mg is fully reimbursed by the health insurer and for this no co-payment is applicable.

Who can submit a claim

Only patients or their carer can claim the Personal Contribution for ONTOZRY® (12.5mg/25mg, 50 mg, 100 mg, 150 mg)  online or by post. Online will be the fastest option. Pharmacists cannot claim this medicine on behalf of the patient.

For more information check out the ONTOZRY® medicine page

You are currently offline. Some pages or content may fail to load.